Intelligence-driven Mechanomedicine for Weight Rebound in Obesity
Current Obesity Reports · 11.04.2026 · 15 (1)
DOI: 10.1007/s13679-026-00714-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Obesity Reports, online erschienen am 11.04.2026. Verfasst von Shanshan Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, P.R. China. Hauptthemen laut MEDLINE: Obesity, Artificial Intelligence, Adipose Tissue, Weight Loss. Die Arbeit nennt 69 Literaturangaben. Gefördert von: Young Talent Fund of Xi'an Association for Science and Technology, Discipline Assistance Program of Tangdu Hospital, National Science and Technology Innovation 2030, Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
PURPOSE OF PERSPECTIVE: This perspective aims to propose a mechanomedicine framework integrating the body’s intrinsic “mechanical intelligence” (MI) with artificial intelligence (AI), offering new potential approaches for diagnosis and treatment of weight rebound. RECENT FINDINGS: Weight rebound after weight loss remains a significant challenge in obesity management. Traditional explanations focus on hormonal and metabolic adaptations, but emerging evidence underscores the importance of mechanical cues in adipose tissue. Persistent fibrosis and extracellular matrix (ECM) stiffness after weight loss may create a mechanical memory that favors weight rebound. We explore the biomechanics of adipose tissue during weight fluctuations, highlight the potential role of mechanobiology, and examine how AI help enhance mechanodiagnostics and mechanotherapy. Both physiological and mechanical factors contribute to weight rebound after initial loss. The integration of MI (biomechanics and mechanobiology) in adipose tissue with AI-driven mechanodiagnostics and mechanotherapy may offer a novel perspective and promising future solutions to prevent weight rebound and transform obesity treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, P.R. China.
- The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, P.R. China.
- Bioinspired Engineering & Biomechanics Center (BEBC), Xi'an Jiaotong University, Xi'an, 710049, P.R. China.
- Department of Endocrinology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, P.R. China. bingao0726@163.com.
- The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, P.R. China. fengxu@mail.xjtu.edu.cn.
- Bioinspired Engineering & Biomechanics Center (BEBC), Xi'an Jiaotong University, Xi'an, 710049, P.R. China. fengxu@mail.xjtu.edu.cn.
Förderung
- Young Talent Fund of Xi'an Association for Science and Technology
- Discipline Assistance Program of Tangdu Hospital
- National Science and Technology Innovation 2030, Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Clinical Research Project of Air Force Medical University
- National Natural Science Foundation of China
- Young Talent Fund of Xi’an Association for Science and Technology
Zitieren
APA
Zhu, S., Cheng, B., Gao, B., & Xu, F. (2026). Intelligence-driven Mechanomedicine for Weight Rebound in Obesity. Current Obesity Reports, 15(1). https://doi.org/10.1007/s13679-026-00714-7
Vancouver
Zhu S, Cheng B, Gao B, Xu F. Intelligence-driven Mechanomedicine for Weight Rebound in Obesity. Current Obesity Reports. 2026;15(1). doi:10.1007/s13679-026-00714-7
BibTeX
@article{Zhu2026,
author = {Zhu, Shanshan and Cheng, Bo and Gao, Bin and Xu, Feng},
title = {Intelligence-driven Mechanomedicine for Weight Rebound in Obesity},
journal = {Current Obesity Reports},
year = {2026},
volume = {15},
number = {1},
doi = {10.1007/s13679-026-00714-7}
}
EUVIMED